Abstract
INTRODUCTION AND OBJECTIVE:Patients with multiple sclerosis (MS) commonly develop obstructive urinary symptoms and urinary retention, which affect quality of life. Although alpha-1 antagonists (A1A...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
